|
|
|
|
|
|
|
|
|
|
Abstract
Interpretation
The risk of all
grade and grade 3–4, hyperglycemia, hypercholesterolemia, and
hypertriglyceridemia, are increase in patients treated with mTOR
inhibitors compared with control.
Thursday, May 16, 2013
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.